Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of FASAB Mark AB (“FASAB”).
Mandate

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of FASAB Mark AB (“FASAB”).

January 13, 2021 Employment and Benefits EU, Competition and Regulatory Environmental Law M&A Intellectual Property Corporate Crime & Compliance Commercial Agreements

FASAB is a local leading supplier of infrastructure services in the northern part of Skåne with a main focus on construction work on behalf of public purchasers via framework agreements with a yearly sales around SEK 300 million. The company’s management team will continue in their respective operational management roles and become shareholders of the Eleda group.

Vinge’s team consisted primarily of partner Christina Kokko and associates Johanna Wiberg and Hanna Risberg (M&A), Isak Willborg (Agreements), Ebba Svenburg (Employment), Rebecka Weitzberg (Intellectual Property), Johan Cederblad and Frida Ställborn (Real Property & Environment), Johan Wahlbom and Joel Kokko (Competition), Tove Lövgren Frisk (Compliance) and Nathalie Hughes (VDR-assistant).

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025